CLINICAL_TRIALS
withdrawal
· 2024-03-12
Clinical Trial Update: Study Evaluating Patients With Cystinuria [Phase 2, Phase 3]
Summary
A cystinuria clinical trial (Phase 2/3) sponsored by Advicenne Pharma was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Advicenne Pharma | Conditions: Cystinuria | Phase 2, Phase 3 | Status: WITHDRAWN